← Back
$DNTH All transactions

Dianthus Therapeutics, Inc. /DE/

M 10b5-1 Plan

$ Value

$0

Shares

27,594

Price

$0

Filed

Mar 26

Insider

Name

Soteropoulos Paula

Title

CIK

0001692444

Roles

Director

Transaction Details

Transaction Date

2026-03-24

Code

M

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

1,198

Footnotes

The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 23, 2025. | The shares of common stock underlying this stock option award vested as to 25% of the shares on April 6, 2023, with the remaining three quarters vesting in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer on each such vesting date.

Filing Info

Accession No.

0001692444-26-000003

Form Type

4

Issuer CIK

0001690585

Soteropoulos Paula's History

Date Ticker Type Value
2026-03-31 DNTH M $5K
2026-03-31 DNTH $48K
2026-03-31 DNTH M $0
2026-03-24 DNTH M $233K
2026-03-24 DNTH $2.2M
2026-03-24 DNTH M $0
2025-05-22 DNTH A $0
2025-05-13 RLYB A $0

Other Insiders at DNTH (90d)

Insider Bought Sold Last
CARR EDWARD
CHIEF ACCOUNTING OFFICER
2026-02-03
Garcia Marino
CEO AND PRESIDENT
2026-02-03
Soteropoulos Paula $2.2M 2026-03-31
Veness Adam M
SVP, General Counsel and Sec.
2026-02-03
Randhawa Simrat
EVP, Head of R&D
2026-02-03
Savitz Ryan
EVP, CFO & CBO
$10.2M 2026-04-09